Overall, these findings explain that miR‐20a‐enriched exosomes derived from CAFs were able to down‐regulate PTEN and thereby regulate the PI3K/AKT pathway in vivo to regulate NSCLC tumour chemoresistance and growth. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.